Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00266656
Status:
COMPLETED
Last Update Posted:
2017-03-31
First Post:
2005-12-15
Brief Title:
Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an extension study that will gather long-term data on the effect of early growth hormone GH treatment on adult height and other aspects of health and development in girls with Turner syndrome The main purpose is to determine whether girls who received 2 years of GH treatment before 6 years of age achieve taller adult height than girls who were untreated during this time The study will also look at middle ear and hearing function and cognitive and behavioral development Protocol completion is defined as attainment of height velocity less than or equal to 10 cmyear or bone age greater than or equal to 15 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B9R-US-GDGH | OTHER | Eli Lilly and Company | None |